Although innovative targeted therapies have positively revolutionized psoriasis treatment
shifting treatment goals to complete or almost complete skin clearance, primary or …

Background: Proteins play a central role in psoriasis as they are involved in the structural
phenotypic changes and inflammation that characterize the disease. This systematic review …

Psoriasis is a chronic immune-mediated condition that affects the skin and joints, with
current treatments still unable to offer a cure and long-term use of treatments posing health …

The clinical exploration of extracellular vesicles (EVs, also called exosomes) in dermatology
has recently grown, including as cosmeceuticals. This systematic review aimed to collate …

Psoriasis is a chronic inflammatory disease affecting skin and joints characterized by a
chronically altered immune and inflammatory response. Several factors occur from the onset …

Psoriasis is a chronic inflammatory polygenic disease with significant impacts on skin and
joints, leading to substantial treatment challenges and healthcare costs. The quest for novel …

It is known that 25%–30% of individuals with cutaneous psoriasis (PsC) will develop
psoriatic arthritis (PsA). To date, the reasons for the development of PsA in individuals with …

Background Psoriasis is a chronic inflammatory disorder characterized by pathogenic
hyperproliferation of keratinocytes and immune dysregulation. Currently, objective …

Psoriasis is a highly prevalent chronic inflammatory skin condition involving abnormal
proliferation and differentiation of keratinocytes, together with substantial infiltration of …

With growing interest in nanotechnology, various nano-based products and applications
have been developed. The use of these nanotech-based materials for medical purposes …